证券简称：通程控股 证券代码：000419 公告编号：2025-030 长沙通程控股股份有限公司 关于控股股东的股东拟发生变更的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、基本情况 长沙通程控股股份有限公司（以下简称"公司"）于 2023 年 12 月 27 日收到实际控制人长沙市人民政府国有资产监督管理委员会 （以下简称"长沙市国资委"）发来的通知，告知根据长沙市委、市 政府的决策部署，长沙市属国有企业将实施改革重组，长沙市国资委 拟将持有的公司控股股东长沙通程实业（集团）有限公司（以下简称 "通程集团"）的全部股权进行无偿划转。该事项不涉及重大资产重 组事项，不涉及公司控股股东、实际控制人发生变更，亦不会对公司 正常生产经营活动构成重大影响。具体内容详见公司于 2023 年 12 月 28 日披露的《长沙通程控股股份有限公司关于控股股东的股东拟 发生变更的提示性公告》（公告编号：2023-045）。 公司于 2024 年 9 月 20 日收到控股股东通程集团发来的《通知》， 告知其收到长沙市国资委下 ...

Core Viewpoint - The company is currently in the process of transferring shares from its controlling shareholder, Tongcheng Group, which has not yet been completed as of October 14, 2025 [1] Group 1 - The company received a notification letter from its controlling shareholder regarding the share transfer [1] - The transfer of state-owned shares from the controlling shareholder is still in progress [1] - The company will continue to monitor the situation and fulfill its information disclosure obligations in a timely manner [1]

Core Viewpoint - Tongcheng Holdings reported that as of September 20, 2025, the total number of shareholders is 24,469 [2] Summary by Category - **Company Information** - Tongcheng Holdings has a total of 24,469 shareholders as of the specified date [2]

Core Viewpoint - The company has effectively utilized the "trade-in" policy and local consumption promotion initiatives to enhance sales and ensure sustainable operations throughout the year [1] Group 1: Business Segments - The company has actively engaged in promotional activities across its electrical appliances, department stores, and hotel sectors [1] - The implementation of the "Hunan Consumption Promotion Special Action Plan" has been a key strategy in driving sales growth [1] Group 2: Operational Strategy - The company has focused on improving professional service levels to benefit consumers and expand sales scale [1] - The approach has resulted in orderly and sustainable business operations, ensuring stability in performance [1]

Group 1 - The company, Tongcheng Holdings, announced on October 9 that it will disclose the shareholder situation as of September 30, 2025, in its third-quarter report for 2025 [2]

Group 1 - The core point of the article is the announcement of a public tender by Changsha Bank for the project named "Changsha Bank Asset Custody Multi-layer Penetration Investment Supervision System" with a budget of 1.2 million yuan [1] - The project is associated with Youa Co., Ltd. and Tongcheng Holdings, which hold shares in the bank at 5.69% and 3.07% respectively [1]

Group 1 - Dongxing Medical plans to acquire 90% equity of Wuhan Yijiaobao for cash, which is expected to constitute a major asset restructuring [1] - Fosun Pharma's subsidiary plans to transfer 100% equity of Shanghai Cloning, with a transaction value of up to 1.256 billion yuan [1] Group 2 - *ST Songfa's subsidiary signed a shipbuilding contract worth approximately 400-600 million USD for four VLCCs, expected delivery between late 2026 and mid-2027 [3] - Qibin Group obtained financing support of up to 90 million yuan for share repurchase [4] Group 3 - Shapuaisi's shareholder plans to reduce holdings by up to 3% of the company's total shares [5] - *ST Kaixin intends to use up to 310 million yuan for cash management in safe and liquid financial products [6] Group 4 - Junchen Technology's shareholders plan to transfer 2.5% of the company's shares due to personal funding needs [7] - Jingliang Holdings received an administrative regulatory measure from Hainan Securities Regulatory Bureau for improper revenue recognition involving 299 million yuan [7] Group 5 - Tongcheng Holdings received a cash dividend of 24.6643 million yuan from Changsha Bank [9] - Shenyang Chemical appointed Chen Liguo as the new general manager [10] Group 6 - Huaguang Huaneng signed a contract for a 160 million yuan waste heat boiler project [15] - Shuxian Valley's subsidiary completed the re-registration of a health food product [16] Group 7 - Xuanta Pharmaceutical's new specification for a diabetes treatment drug was approved [17] - Panlong Pharmaceutical's application for a pain relief gel patch was accepted by the drug regulatory authority [18] Group 8 - Zhiguang Electric's subsidiary won a procurement contract worth 164 million yuan for a storage system [19] - Chitianhua's production facility resumed operations after maintenance [20] Group 9 - Haitong Development's application for a specific A-share issuance was accepted by the Shanghai Stock Exchange, aiming to raise 210 million yuan [20] - Risheng Technology's shareholders plan to transfer 4.02% of the company's shares [33] Group 10 - Pingmei Shares' controlling shareholder plans a strategic restructuring with Henan Energy Group [35] - Shenghui Integration's controlling shareholder committed not to reduce shareholdings for 12 months [37] Group 11 - Agricultural Bank and Bank of China will no longer establish supervisory boards, with their functions transferred to the audit committees [39][40] - Dongfang Yuhong's subsidiary signed a contract for a seawater pipeline project worth 2.524 billion USD [40][41] Group 12 - Ganfeng Lithium plans to introduce investors for a capital increase of up to 2.5 billion yuan [50] - Hanyu Pharmaceutical intends to raise up to 968 million yuan for various projects [51]

（编辑 楚丽君） 证券日报网讯 9月26日晚间，通程控股发布公告称，长沙通程控股股份有限公司（以下简称"公司"）现 持有长沙银行股份有限公司（以下简称"长沙银行"）无限售条件A股123，321，299.00股，持股比例为 3.07%。长沙银行于2025年9月19日公告了《长沙银行2025年半年度权益分派实施公告》。长沙银行 2025年半年度权益分派方案为：以方案实施前的长沙银行总股本4，021，553，754股为基数，向全体股 东每股派发现金红利0.20元（含税）。根据上述分配方案，公司可分得现金股利24，664，259.80元。公 司于2025年9月26日收到长沙银行该笔现金分红款。 ...

通程控股（000419）(000419.SZ)公告，公司持有长沙银行无限售条件A股1.23亿股，持股比例为 3.07%。根据分配方案，公司可分得现金股利2466.43万元。公司于2025年9月26日收到长沙银行该笔现 金分红款。 ...

Group 1 - The company holds 123 million shares of Changsha Bank, accounting for 3.07% of the total shares [1] - The company will receive a cash dividend of 24.6643 million yuan based on the distribution plan [1] - The cash dividend payment is scheduled to be received on September 26, 2025 [1]